FOSL1 is a key regulator of a super-enhancer driving TCOF1 expression in triple-negative breast cancer.

Epigenetics Chromatin · 2024 · PMC11552368 · PMID 39523372

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

did not reach statistical significancep = 0.052so close (0.05 < p ≤ 0.1)

showed a trendp = 0.052so close (0.05 < p ≤ 0.1)

Although the results did not reach statistical significance, high expression of FOSL1 showed a trend towards poor prognosis in patients ( p = 0.052) (Fig. 1 E).

also in 33,481 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.